ADC binds TROP2 on tumor cells, is internalized, and releases SN-38, a topoisomerase I inhibitor that causes DNA damage (Topo I–DNA complex stabilization), S‑phase arrest, and apoptosis; membrane-permeable SN‑38 can also cause a bystander effect.